Global Cell and Gene Therapy Manufacturing QC Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 111

Published Date: 11 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Cell and Gene Therapy Manufacturing QC market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Cell and Gene Therapy Manufacturing QC market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Cell and Gene Therapy Manufacturing QC market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cell and Gene Therapy Manufacturing QC market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cell and Gene Therapy Manufacturing QC market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cell and Gene Therapy Manufacturing QC market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell and Gene Therapy Manufacturing QC
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell and Gene Therapy Manufacturing QC market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Techne Corporation, BioMerieux SA, Catalent, Inc., Charles River Laboratories International Inc. and Eurofins Scientific SE, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Cell and Gene Therapy Manufacturing QC market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Safety Testing
    Purity Testing
    Potency Testing
    Identity Testing
    Stability Testing

Market segment by Application
    Precision Therapy
    Biological Research

Market segment by players, this report covers
    Bio-Techne Corporation
    BioMerieux SA
    Catalent, Inc.
    Charles River Laboratories International Inc.
    Eurofins Scientific SE
    F. Hoffmann-La Roche Ltd
    Intertek Group plc
    Lonza Group AG
    Merck KGaA
    Sartorius AG
    SGS S.A.
    Sistemic Scotland Limited
    Thermo Fisher Scientific Inc.
    Vigene Biosciences, Inc.
    WuXi AppTec

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy Manufacturing QC product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy Manufacturing QC, with revenue, gross margin and global market share of Cell and Gene Therapy Manufacturing QC from 2018 to 2023.
Chapter 3, the Cell and Gene Therapy Manufacturing QC competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell and Gene Therapy Manufacturing QC market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy Manufacturing QC.
Chapter 13, to describe Cell and Gene Therapy Manufacturing QC research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Cell and Gene Therapy Manufacturing QC
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Cell and Gene Therapy Manufacturing QC by Type
        1.3.1 Overview: Global Cell and Gene Therapy Manufacturing QC Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Type in 2022
        1.3.3 Safety Testing
        1.3.4 Purity Testing
        1.3.5 Potency Testing
        1.3.6 Identity Testing
        1.3.7 Stability Testing
    1.4 Global Cell and Gene Therapy Manufacturing QC Market by Application
        1.4.1 Overview: Global Cell and Gene Therapy Manufacturing QC Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Precision Therapy
        1.4.3 Biological Research
    1.5 Global Cell and Gene Therapy Manufacturing QC Market Size & Forecast
    1.6 Global Cell and Gene Therapy Manufacturing QC Market Size and Forecast by Region
        1.6.1 Global Cell and Gene Therapy Manufacturing QC Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Cell and Gene Therapy Manufacturing QC Market Size by Region, (2018-2029)
        1.6.3 North America Cell and Gene Therapy Manufacturing QC Market Size and Prospect (2018-2029)
        1.6.4 Europe Cell and Gene Therapy Manufacturing QC Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size and Prospect (2018-2029)
        1.6.6 South America Cell and Gene Therapy Manufacturing QC Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Cell and Gene Therapy Manufacturing QC Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Bio-Techne Corporation
        2.1.1 Bio-Techne Corporation Details
        2.1.2 Bio-Techne Corporation Major Business
        2.1.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Product and Solutions
        2.1.4 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Bio-Techne Corporation Recent Developments and Future Plans
    2.2 BioMerieux SA
        2.2.1 BioMerieux SA Details
        2.2.2 BioMerieux SA Major Business
        2.2.3 BioMerieux SA Cell and Gene Therapy Manufacturing QC Product and Solutions
        2.2.4 BioMerieux SA Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 BioMerieux SA Recent Developments and Future Plans
    2.3 Catalent, Inc.
        2.3.1 Catalent, Inc. Details
        2.3.2 Catalent, Inc. Major Business
        2.3.3 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions
        2.3.4 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Catalent, Inc. Recent Developments and Future Plans
    2.4 Charles River Laboratories International Inc.
        2.4.1 Charles River Laboratories International Inc. Details
        2.4.2 Charles River Laboratories International Inc. Major Business
        2.4.3 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions
        2.4.4 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Charles River Laboratories International Inc. Recent Developments and Future Plans
    2.5 Eurofins Scientific SE
        2.5.1 Eurofins Scientific SE Details
        2.5.2 Eurofins Scientific SE Major Business
        2.5.3 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Product and Solutions
        2.5.4 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Eurofins Scientific SE Recent Developments and Future Plans
    2.6 F. Hoffmann-La Roche Ltd
        2.6.1 F. Hoffmann-La Roche Ltd Details
        2.6.2 F. Hoffmann-La Roche Ltd Major Business
        2.6.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Product and Solutions
        2.6.4 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
    2.7 Intertek Group plc
        2.7.1 Intertek Group plc Details
        2.7.2 Intertek Group plc Major Business
        2.7.3 Intertek Group plc Cell and Gene Therapy Manufacturing QC Product and Solutions
        2.7.4 Intertek Group plc Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Intertek Group plc Recent Developments and Future Plans
    2.8 Lonza Group AG
        2.8.1 Lonza Group AG Details
        2.8.2 Lonza Group AG Major Business
        2.8.3 Lonza Group AG Cell and Gene Therapy Manufacturing QC Product and Solutions
        2.8.4 Lonza Group AG Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Lonza Group AG Recent Developments and Future Plans
    2.9 Merck KGaA
        2.9.1 Merck KGaA Details
        2.9.2 Merck KGaA Major Business
        2.9.3 Merck KGaA Cell and Gene Therapy Manufacturing QC Product and Solutions
        2.9.4 Merck KGaA Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Merck KGaA Recent Developments and Future Plans
    2.10 Sartorius AG
        2.10.1 Sartorius AG Details
        2.10.2 Sartorius AG Major Business
        2.10.3 Sartorius AG Cell and Gene Therapy Manufacturing QC Product and Solutions
        2.10.4 Sartorius AG Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Sartorius AG Recent Developments and Future Plans
    2.11 SGS S.A.
        2.11.1 SGS S.A. Details
        2.11.2 SGS S.A. Major Business
        2.11.3 SGS S.A. Cell and Gene Therapy Manufacturing QC Product and Solutions
        2.11.4 SGS S.A. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 SGS S.A. Recent Developments and Future Plans
    2.12 Sistemic Scotland Limited
        2.12.1 Sistemic Scotland Limited Details
        2.12.2 Sistemic Scotland Limited Major Business
        2.12.3 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Product and Solutions
        2.12.4 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Sistemic Scotland Limited Recent Developments and Future Plans
    2.13 Thermo Fisher Scientific Inc.
        2.13.1 Thermo Fisher Scientific Inc. Details
        2.13.2 Thermo Fisher Scientific Inc. Major Business
        2.13.3 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions
        2.13.4 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
    2.14 Vigene Biosciences, Inc.
        2.14.1 Vigene Biosciences, Inc. Details
        2.14.2 Vigene Biosciences, Inc. Major Business
        2.14.3 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions
        2.14.4 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Vigene Biosciences, Inc. Recent Developments and Future Plans
    2.15 WuXi AppTec
        2.15.1 WuXi AppTec Details
        2.15.2 WuXi AppTec Major Business
        2.15.3 WuXi AppTec Cell and Gene Therapy Manufacturing QC Product and Solutions
        2.15.4 WuXi AppTec Cell and Gene Therapy Manufacturing QC Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 WuXi AppTec Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Cell and Gene Therapy Manufacturing QC Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Cell and Gene Therapy Manufacturing QC by Company Revenue
        3.2.2 Top 3 Cell and Gene Therapy Manufacturing QC Players Market Share in 2022
        3.2.3 Top 6 Cell and Gene Therapy Manufacturing QC Players Market Share in 2022
    3.3 Cell and Gene Therapy Manufacturing QC Market: Overall Company Footprint Analysis
        3.3.1 Cell and Gene Therapy Manufacturing QC Market: Region Footprint
        3.3.2 Cell and Gene Therapy Manufacturing QC Market: Company Product Type Footprint
        3.3.3 Cell and Gene Therapy Manufacturing QC Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Cell and Gene Therapy Manufacturing QC Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Cell and Gene Therapy Manufacturing QC Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Application (2018-2023)
    5.2 Global Cell and Gene Therapy Manufacturing QC Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2018-2029)
    6.2 North America Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2018-2029)
    6.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Country
        6.3.1 North America Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2018-2029)
        6.3.2 United States Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)
        6.3.3 Canada Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)
        6.3.4 Mexico Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2018-2029)
    7.2 Europe Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2018-2029)
    7.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country
        7.3.1 Europe Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2018-2029)
        7.3.2 Germany Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)
        7.3.3 France Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)
        7.3.5 Russia Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)
        7.3.6 Italy Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region
        8.3.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value by Region (2018-2029)
        8.3.2 China Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)
        8.3.3 Japan Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)
        8.3.4 South Korea Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)
        8.3.5 India Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)
        8.3.7 Australia Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2018-2029)
    9.2 South America Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2018-2029)
    9.3 South America Cell and Gene Therapy Manufacturing QC Market Size by Country
        9.3.1 South America Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2018-2029)
        9.3.2 Brazil Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)
        9.3.3 Argentina Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country
        10.3.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2018-2029)
        10.3.2 Turkey Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)
        10.3.4 UAE Cell and Gene Therapy Manufacturing QC Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Cell and Gene Therapy Manufacturing QC Market Drivers
    11.2 Cell and Gene Therapy Manufacturing QC Market Restraints
    11.3 Cell and Gene Therapy Manufacturing QC Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Cell and Gene Therapy Manufacturing QC Industry Chain
    12.2 Cell and Gene Therapy Manufacturing QC Upstream Analysis
    12.3 Cell and Gene Therapy Manufacturing QC Midstream Analysis
    12.4 Cell and Gene Therapy Manufacturing QC Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Cell and Gene Therapy Manufacturing QC Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Cell and Gene Therapy Manufacturing QC Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Cell and Gene Therapy Manufacturing QC Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Cell and Gene Therapy Manufacturing QC Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Bio-Techne Corporation Company Information, Head Office, and Major Competitors
    Table 6. Bio-Techne Corporation Major Business
    Table 7. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Product and Solutions
    Table 8. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Bio-Techne Corporation Recent Developments and Future Plans
    Table 10. BioMerieux SA Company Information, Head Office, and Major Competitors
    Table 11. BioMerieux SA Major Business
    Table 12. BioMerieux SA Cell and Gene Therapy Manufacturing QC Product and Solutions
    Table 13. BioMerieux SA Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. BioMerieux SA Recent Developments and Future Plans
    Table 15. Catalent, Inc. Company Information, Head Office, and Major Competitors
    Table 16. Catalent, Inc. Major Business
    Table 17. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions
    Table 18. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Catalent, Inc. Recent Developments and Future Plans
    Table 20. Charles River Laboratories International Inc. Company Information, Head Office, and Major Competitors
    Table 21. Charles River Laboratories International Inc. Major Business
    Table 22. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions
    Table 23. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Charles River Laboratories International Inc. Recent Developments and Future Plans
    Table 25. Eurofins Scientific SE Company Information, Head Office, and Major Competitors
    Table 26. Eurofins Scientific SE Major Business
    Table 27. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Product and Solutions
    Table 28. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Eurofins Scientific SE Recent Developments and Future Plans
    Table 30. F. Hoffmann-La Roche Ltd Company Information, Head Office, and Major Competitors
    Table 31. F. Hoffmann-La Roche Ltd Major Business
    Table 32. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Product and Solutions
    Table 33. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
    Table 35. Intertek Group plc Company Information, Head Office, and Major Competitors
    Table 36. Intertek Group plc Major Business
    Table 37. Intertek Group plc Cell and Gene Therapy Manufacturing QC Product and Solutions
    Table 38. Intertek Group plc Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Intertek Group plc Recent Developments and Future Plans
    Table 40. Lonza Group AG Company Information, Head Office, and Major Competitors
    Table 41. Lonza Group AG Major Business
    Table 42. Lonza Group AG Cell and Gene Therapy Manufacturing QC Product and Solutions
    Table 43. Lonza Group AG Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Lonza Group AG Recent Developments and Future Plans
    Table 45. Merck KGaA Company Information, Head Office, and Major Competitors
    Table 46. Merck KGaA Major Business
    Table 47. Merck KGaA Cell and Gene Therapy Manufacturing QC Product and Solutions
    Table 48. Merck KGaA Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Merck KGaA Recent Developments and Future Plans
    Table 50. Sartorius AG Company Information, Head Office, and Major Competitors
    Table 51. Sartorius AG Major Business
    Table 52. Sartorius AG Cell and Gene Therapy Manufacturing QC Product and Solutions
    Table 53. Sartorius AG Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Sartorius AG Recent Developments and Future Plans
    Table 55. SGS S.A. Company Information, Head Office, and Major Competitors
    Table 56. SGS S.A. Major Business
    Table 57. SGS S.A. Cell and Gene Therapy Manufacturing QC Product and Solutions
    Table 58. SGS S.A. Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. SGS S.A. Recent Developments and Future Plans
    Table 60. Sistemic Scotland Limited Company Information, Head Office, and Major Competitors
    Table 61. Sistemic Scotland Limited Major Business
    Table 62. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Product and Solutions
    Table 63. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Sistemic Scotland Limited Recent Developments and Future Plans
    Table 65. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
    Table 66. Thermo Fisher Scientific Inc. Major Business
    Table 67. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions
    Table 68. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
    Table 70. Vigene Biosciences, Inc. Company Information, Head Office, and Major Competitors
    Table 71. Vigene Biosciences, Inc. Major Business
    Table 72. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Product and Solutions
    Table 73. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Vigene Biosciences, Inc. Recent Developments and Future Plans
    Table 75. WuXi AppTec Company Information, Head Office, and Major Competitors
    Table 76. WuXi AppTec Major Business
    Table 77. WuXi AppTec Cell and Gene Therapy Manufacturing QC Product and Solutions
    Table 78. WuXi AppTec Cell and Gene Therapy Manufacturing QC Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. WuXi AppTec Recent Developments and Future Plans
    Table 80. Global Cell and Gene Therapy Manufacturing QC Revenue (USD Million) by Players (2018-2023)
    Table 81. Global Cell and Gene Therapy Manufacturing QC Revenue Share by Players (2018-2023)
    Table 82. Breakdown of Cell and Gene Therapy Manufacturing QC by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 83. Market Position of Players in Cell and Gene Therapy Manufacturing QC, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 84. Head Office of Key Cell and Gene Therapy Manufacturing QC Players
    Table 85. Cell and Gene Therapy Manufacturing QC Market: Company Product Type Footprint
    Table 86. Cell and Gene Therapy Manufacturing QC Market: Company Product Application Footprint
    Table 87. Cell and Gene Therapy Manufacturing QC New Market Entrants and Barriers to Market Entry
    Table 88. Cell and Gene Therapy Manufacturing QC Mergers, Acquisition, Agreements, and Collaborations
    Table 89. Global Cell and Gene Therapy Manufacturing QC Consumption Value (USD Million) by Type (2018-2023)
    Table 90. Global Cell and Gene Therapy Manufacturing QC Consumption Value Share by Type (2018-2023)
    Table 91. Global Cell and Gene Therapy Manufacturing QC Consumption Value Forecast by Type (2024-2029)
    Table 92. Global Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2018-2023)
    Table 93. Global Cell and Gene Therapy Manufacturing QC Consumption Value Forecast by Application (2024-2029)
    Table 94. North America Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2018-2023) & (USD Million)
    Table 95. North America Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2024-2029) & (USD Million)
    Table 96. North America Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2018-2023) & (USD Million)
    Table 97. North America Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2024-2029) & (USD Million)
    Table 98. North America Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2018-2023) & (USD Million)
    Table 99. North America Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2024-2029) & (USD Million)
    Table 100. Europe Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2018-2023) & (USD Million)
    Table 101. Europe Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2024-2029) & (USD Million)
    Table 102. Europe Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2018-2023) & (USD Million)
    Table 103. Europe Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2024-2029) & (USD Million)
    Table 104. Europe Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2018-2023) & (USD Million)
    Table 105. Europe Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2024-2029) & (USD Million)
    Table 106. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2018-2023) & (USD Million)
    Table 107. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2024-2029) & (USD Million)
    Table 108. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2018-2023) & (USD Million)
    Table 109. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2024-2029) & (USD Million)
    Table 110. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value by Region (2018-2023) & (USD Million)
    Table 111. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value by Region (2024-2029) & (USD Million)
    Table 112. South America Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2018-2023) & (USD Million)
    Table 113. South America Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2024-2029) & (USD Million)
    Table 114. South America Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2018-2023) & (USD Million)
    Table 115. South America Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2024-2029) & (USD Million)
    Table 116. South America Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2018-2023) & (USD Million)
    Table 117. South America Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2024-2029) & (USD Million)
    Table 118. Middle East & Africa Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2018-2023) & (USD Million)
    Table 119. Middle East & Africa Cell and Gene Therapy Manufacturing QC Consumption Value by Type (2024-2029) & (USD Million)
    Table 120. Middle East & Africa Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2018-2023) & (USD Million)
    Table 121. Middle East & Africa Cell and Gene Therapy Manufacturing QC Consumption Value by Application (2024-2029) & (USD Million)
    Table 122. Middle East & Africa Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2018-2023) & (USD Million)
    Table 123. Middle East & Africa Cell and Gene Therapy Manufacturing QC Consumption Value by Country (2024-2029) & (USD Million)
    Table 124. Cell and Gene Therapy Manufacturing QC Raw Material
    Table 125. Key Suppliers of Cell and Gene Therapy Manufacturing QC Raw Materials
List of Figures
    Figure 1. Cell and Gene Therapy Manufacturing QC Picture
    Figure 2. Global Cell and Gene Therapy Manufacturing QC Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Type in 2022
    Figure 4. Safety Testing
    Figure 5. Purity Testing
    Figure 6. Potency Testing
    Figure 7. Identity Testing
    Figure 8. Stability Testing
    Figure 9. Global Cell and Gene Therapy Manufacturing QC Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 10. Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Application in 2022
    Figure 11. Precision Therapy Picture
    Figure 12. Biological Research Picture
    Figure 13. Global Cell and Gene Therapy Manufacturing QC Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Cell and Gene Therapy Manufacturing QC Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Market Cell and Gene Therapy Manufacturing QC Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 16. Global Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Region (2018-2029)
    Figure 17. Global Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Region in 2022
    Figure 18. North America Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 20. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 21. South America Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 22. Middle East and Africa Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 23. Global Cell and Gene Therapy Manufacturing QC Revenue Share by Players in 2022
    Figure 24. Cell and Gene Therapy Manufacturing QC Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 25. Global Top 3 Players Cell and Gene Therapy Manufacturing QC Market Share in 2022
    Figure 26. Global Top 6 Players Cell and Gene Therapy Manufacturing QC Market Share in 2022
    Figure 27. Global Cell and Gene Therapy Manufacturing QC Consumption Value Share by Type (2018-2023)
    Figure 28. Global Cell and Gene Therapy Manufacturing QC Market Share Forecast by Type (2024-2029)
    Figure 29. Global Cell and Gene Therapy Manufacturing QC Consumption Value Share by Application (2018-2023)
    Figure 30. Global Cell and Gene Therapy Manufacturing QC Market Share Forecast by Application (2024-2029)
    Figure 31. North America Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Type (2018-2029)
    Figure 32. North America Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Application (2018-2029)
    Figure 33. North America Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Country (2018-2029)
    Figure 34. United States Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 35. Canada Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 36. Mexico Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 37. Europe Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Type (2018-2029)
    Figure 38. Europe Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Application (2018-2029)
    Figure 39. Europe Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Country (2018-2029)
    Figure 40. Germany Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 41. France Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 42. United Kingdom Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 43. Russia Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 44. Italy Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 45. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Type (2018-2029)
    Figure 46. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Application (2018-2029)
    Figure 47. Asia-Pacific Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Region (2018-2029)
    Figure 48. China Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 49. Japan Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 50. South Korea Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 51. India Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 52. Southeast Asia Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 53. Australia Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 54. South America Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Type (2018-2029)
    Figure 55. South America Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Application (2018-2029)
    Figure 56. South America Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Country (2018-2029)
    Figure 57. Brazil Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 58. Argentina Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 59. Middle East and Africa Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Type (2018-2029)
    Figure 60. Middle East and Africa Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Application (2018-2029)
    Figure 61. Middle East and Africa Cell and Gene Therapy Manufacturing QC Consumption Value Market Share by Country (2018-2029)
    Figure 62. Turkey Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 63. Saudi Arabia Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 64. UAE Cell and Gene Therapy Manufacturing QC Consumption Value (2018-2029) & (USD Million)
    Figure 65. Cell and Gene Therapy Manufacturing QC Market Drivers
    Figure 66. Cell and Gene Therapy Manufacturing QC Market Restraints
    Figure 67. Cell and Gene Therapy Manufacturing QC Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Cell and Gene Therapy Manufacturing QC in 2022
    Figure 70. Manufacturing Process Analysis of Cell and Gene Therapy Manufacturing QC
    Figure 71. Cell and Gene Therapy Manufacturing QC Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Cell and Gene Therapy Manufacturing QC Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Cell and Gene Therapy Manufacturing QC Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 08 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Cell and Gene Therapy Manufacturing QC market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Cell and Gene Therapy Manufacturing QC

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>